For: | Pantazopoulos IN, Troupis GT, Pantazopoulos CN, Xanthos TT. Nifekalant in the treatment of life-threatening ventricular tachyarrhythmias. World J Cardiol 2011; 3(6): 169-176 [PMID: 21772943 DOI: 10.4330/wjc.v3.i6.169] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v3/i6/169.htm |
Number | Citing Articles |
1 |
|
2 |
Frank Zoerner, Egidijus Semenas. Resuscitation with amiodarone increases survival after hemorrhage and ventricular fibrillation in pigs. Journal of Trauma and Acute Care Surgery 2014; 76(6): 1402 doi: 10.1097/TA.0000000000000243
|
3 |
Juanjuan Jiang, Li Xu, Lin Chai, Li Zhang, Hong Liu, Yan Yan, Xiaoyuan Guan, Hui Sun, Lei Tian. Population pharmacokinetic/pharmacodynamic modeling of nifekalant injection with varies dosing plan in Chinese volunteers: a randomized, blind, placebo-controlled study. Journal of Pharmacokinetics and Pharmacodynamics 2024; 51(1): 77 doi: 10.1007/s10928-023-09882-8
|
4 |
G. KARLIS, N. IACOVIDOU, P. LELOVAS, P. NIFOROPOULOU, A. ZACHARIOUDAKI, A. PAPALOIS, K. SUNDE, P. A. STEEN, T. XANTHOS. Effects of early amiodarone administration during and immediately after cardiopulmonary resuscitation in a swine model. Acta Anaesthesiologica Scandinavica 2014; 58(1): 114 doi: 10.1111/aas.12226
|
5 |
Jiashan Zhang, Ying Zan, Hua Huo, Yanfang Liu, Yunbiao Tang, Yaling Han. Population pharmacokinetic/pharmacodynamic modelling of nifekalant in healthy Chinese volunteers. European Journal of Pharmaceutical Sciences 2020; 151: 105385 doi: 10.1016/j.ejps.2020.105385
|
6 |
Takashi Tagami, Hideo Yasunaga, Hiroyuki Yokota. Antiarrhythmic drugs for out-of-hospital cardiac arrest with refractory ventricular fibrillation. Critical Care 2017; 21(1) doi: 10.1186/s13054-017-1639-8
|
7 |
T. Tagami, H. Yasunaga, H. Yokota. Annual Update in Intensive Care and Emergency Medicine 2017. Annual Update in Intensive Care and Emergency Medicine 2017; : 213 doi: 10.1007/978-3-319-51908-1_18
|
8 |
Brit Long, Alex Koyfman. Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia. The Journal of Emergency Medicine 2017; 52(4): 484 doi: 10.1016/j.jemermed.2016.09.010
|
9 |
George Karlis, Nicoletta Iacovidou, Pavlos Lelovas, Panagiota Niforopoulou, Apostolos Papalois, Ioanna Siafaka, Spyros Mentzelopoulos, Theodoros Xanthos. Nifekalant Versus Amiodarone in the Treatment of Cardiac Arrest: an Experimental Study in a Swine Model of Prolonged Ventricular Fibrillation. Cardiovascular Drugs and Therapy 2015; 29(5): 425 doi: 10.1007/s10557-015-6604-7
|
10 |
Takashi Tagami, Hiroki Matsui, Saori Ishinokami, Masao Oyanagi, Akiko Kitahashi, Reo Fukuda, Kyoko Unemoto, Kiyohide Fushimi, Hideo Yasunaga. Amiodarone or nifekalant upon hospital arrival for refractory ventricular fibrillation after out-of-hospital cardiac arrest. Resuscitation 2016; 109: 127 doi: 10.1016/j.resuscitation.2016.08.017
|
11 |
Aiyana M. Emigh Cortez, Kevin R. DeMarco, Kazuharu Furutani, Slava Bekker, Jon T. Sack, Heike Wulff, Colleen E. Clancy, Igor Vorobyov, Vladimir Yarov-Yarovoy. Structural modeling of hERG channel–drug interactions using Rosetta. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1244166
|
12 |
George Karlis, Sevasti Afantenou. Drugs in cardiac arrest: the rise and fall of antiarrhythmics. Acta Cardiologica 2018; 73(4): 325 doi: 10.1080/00015385.2017.1389803
|
13 |
Yukio Hayashi, Mika Sakai, Yosuke Tachibana, Emiri Saiki, Yuka Miyata. Pharmacological cardioversion by nifekalant after release of the aortic cross‐clamp during cardiac surgery. Anaesthesia Cases 2018; 6(2): 25 doi: 10.21466/ac.PCBNARO.2018
|
14 |
Ageliki Laina, George Karlis, Aris Liakos, Georgios Georgiopoulos, Dimitrios Oikonomou, Evangelia Kouskouni, Athanasios Chalkias, Theodoros Xanthos. Amiodarone and cardiac arrest: Systematic review and meta-analysis. International Journal of Cardiology 2016; 221: 780 doi: 10.1016/j.ijcard.2016.07.138
|